Tomocube Inc
475960
Company Profile
Business description
Tomocube Inc is a technology-based company that provides solutions in life science research and diagnosis. The group's Core technology, holotomography, is a non-invasive imaging technique that uses light diffraction to acquire three-dimensional images of cells and tissues without dyeing or labeling. Its products and applications are Holotomography includes HT-X1, HT-X1, and HT-2H, TomoAnalysis, Accessories Cell biology, Regenerative medicine, 3D biology, Immunology, and LLPS.
Contact
155 Shinsung-ro
4th floor
Yuseong-gu
Daejeon34109
KORT: +82 428631100
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2026
Employees
76
Stocks News & Analysis
stocks
Is this ASX share a value trap or bargain?
Cost-cutting the priority as underlying asset values falling on deaf ears.
stocks
Goldman Sachs Earnings: Valuations remain stretched
We raise our fair value estimate for Goldman Sachs stock.
stocks
Major ASX listed miners overvalued
We’ve adjusted our fair values after updating our commodity price assumptions.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,143.30 | 15.00 | -0.16% |
| CAC 40 | 8,112.02 | 146.92 | -1.78% |
| DAX 40 | 24,959.06 | 338.07 | -1.34% |
| Dow JONES (US) | 49,359.33 | 83.11 | -0.17% |
| FTSE 100 | 10,195.35 | 39.94 | -0.39% |
| HKSE | 26,552.57 | 11.33 | -0.04% |
| NASDAQ | 23,515.39 | 14.63 | -0.06% |
| Nikkei 225 | 52,984.25 | 599.32 | -1.12% |
| NZX 50 Index | 13,545.09 | 35.20 | -0.26% |
| S&P 500 | 6,940.01 | 4.46 | -0.06% |
| S&P/ASX 200 | 8,822.10 | 14.50 | -0.16% |
| SSE Composite Index | 4,101.62 | 12.38 | -0.30% |